Answers are grounded in this paper and cite their sources.
Advances in cell biology and genomics have uncovered a number of oncogenic pathways and identified unique molecular signatures of a variety of cancers previously treatable only with relatively non-specific chemotherapeutic agents. Coupled with corresponding advances in medicinal chemistry, oncologists now have at their disposal highly targeted/ specific therapies that can be personalised to suit individual patients
No takes yet. Share an insight, caveat, or question.
Shah et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: